A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis

Clinical trial NCT02654769 · COMPLETED

Trial details

NCT number: NCT02654769
Sponsor: Actavis Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2015-02-01
Primary completion: 2015-09-01
Enrollment: 441

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.